Dr Simon Hirst is a medicinal chemist with over 30 years of experience in the pharmaceutical industry. Simon has a BSc (Hons.) in chemistry and a PhD in synthetic organic chemistry from the University of Nottingham, and undertook post-doctoral research at the University of Pittsburgh. Simon founded Sygnature in 2004 with a vision to deliver advanced scientific research into medicinal drug discovery programmes for pharmaceutical and biotechnology companies worldwide and to accelerate new medicines into development for patients. Today Sygnature Discovery is the UK’s largest independent provider of integrated drug discovery expertise. Core capabilities include medicinal chemistry, in-vitro bioscience, computational chemistry and DMPK & Physical Sciences.